Neurological Sciences

, Volume 29, Supplement 5, pp 392–396 | Cite as

The rationale for improved integration between home care and neurology hospital services in patients with advanced Parkinson’s disease

  • Angelo Antonini
  • Luisa Mirò
  • Carlo Castiglioni
  • Gianni Pezzoli
Article

Abstract

Management of patients with advanced Parkinson’s disease (PD) should benefit from improved integration between in-hospital services and home care. In Italy the number of PD hospital admissions is large but there are no guidelines of appropriateness to address queries of health authorities on resource allocation. Reasons for hospitalisation are often linked primarily to the occurrence of falls or infections leading to admission in internal medicine wards rather than neurology. This could be reduced if severe patients were provided with regular nursing and rehabilitation services at their homes and neurologists were actively involved in this process. Moreover, the application of infusion therapies (apomorphine or duodenal levodopa infusion) or deep brain stimulation would require integration with home care services after patient discharge. Here we propose a management algorithm that we believe would facilitate care and eventually lead to an optimisation of resource allocations for advanced PD patients. This would reduce unnecessary internal medicine hospitalisations and further highlight the role of neurologists as a key health care figure.

Keywords

Parkinson disease Home care Hospitalisation costs Disease management 

References

  1. 1.
    McCrone P, Allcock LM, Burn DJ (2007) Predicting the cost of Parkinson’s disease. Mov Disord 22:804–812PubMedCrossRefGoogle Scholar
  2. 2.
    Leibson CL, Long KH, Maraganore DM et al (2006) Direct medical costs associated with Parkinson’s disease: a population-based study. Mov Disord 21:1864–1871PubMedCrossRefGoogle Scholar
  3. 3.
    Watts JJ, McGinley JL, Huxham F et al (2008) Cost effectiveness of preventing falls and improving mobility in people with Parkinson disease: protocol for an economic evaluation alongside a clinical trial. BMC Geriatr 8:23PubMedCrossRefGoogle Scholar
  4. 4.
    D’Ausilio A, Marconi S, Antonini A et al (2003) [Cost analysis in Italy of various strategies for the treatment of Parkinson disease in the advanced phase.] Recenti Prog Med 94:484–493PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • Angelo Antonini
    • 1
  • Luisa Mirò
    • 2
  • Carlo Castiglioni
    • 2
  • Gianni Pezzoli
    • 1
  1. 1.Parkinson Institute MilanIstituti Clinici di PerfezionamentoMilanItaly
  2. 2.VitalAir Medicasa MilanMilanItaly

Personalised recommendations